Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Theresa Margaretha Dolejsi, M.D., Ph.D.

Concepts (48)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Theresa Dolejsi's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Theresa Dolejsi has written about over time.
Angiotensin Receptor Antagonists, 1 publications between 2021 and 2021, average publication date June 2021. Angiotensin-Converting Enzyme Inhibitors, 1 publications between 2021 and 2021, average publication date June 2021. Renin-Angiotensin System, 1 publications between 2021 and 2021, average publication date June 2021. Asymptomatic Diseases, 1 publications between 2021 and 2021, average publication date July 2021. Monitoring, Ambulatory, 1 publications between 2021 and 2021, average publication date July 2021. Telemedicine, 2 publications between 2021 and 2022, average publication date October 2021. Arrhythmias, Cardiac, 1 publications between 2022 and 2022, average publication date February 2022. Monitoring, Physiologic, 1 publications between 2022 and 2022, average publication date February 2022. Atrial Fibrillation, 2 publications between 2021 and 2022, average publication date February 2022. Fibrosis, 1 publications between 2022 and 2022, average publication date July 2022. Interferon-gamma, 1 publications between 2022 and 2022, average publication date July 2022. Myocardial Infarction, 3 publications between 2022 and 2024, average publication date February 2023. Myocytes, Cardiac, 2 publications between 2022 and 2024, average publication date August 2023. Regeneration, 2 publications between 2022 and 2024, average publication date August 2023. STAT1 Transcription Factor, 1 publications between 2024 and 2024, average publication date July 2024. Animals, Newborn, 1 publications between 2024 and 2024, average publication date September 2024. Receptor, IGF Type 1, 1 publications between 2024 and 2024, average publication date September 2024.

To see the data from this visualization as text, click here.
Dolejsi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (48)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.